Abstract
Fusariosis has presented a significant increase in their incidence in the last years. This epidemiological panorama probably is due to the increasing profile of refractory susceptibility of Fusarium spp. to available drugs, especially in immunocompromised individuals. Thus, the development of new compounds with effectiveness on these organisms is a necessity. This study evaluated the antifungal potential of a chloroacetamide derivative (4-BFCA) against resistant Fusarium strains. As a result, the compound was effective against all strains (MIC range 12.5–50 μg/mL). The time kill assay demonstrated that 4-BFCA presents a concentration-dependent fungicidal action. Although its action mechanism has not yet been elucidated, it was possible to observe its efficacy through damages and alterations provoked along the hyphae of Fusarium spp. 4-BFCA maintained a high survival rate of Tenebrio molitor larvae, suggesting that it does not cause acute systemic toxicity on this host at the concentration evaluated. In addition, 4-BFCA was 83.33% effective in combating a fungal infection in vivo on the chorioallantoid membrane of embryonated eggs. Our results are very promising and arouse interest to investigate the action of 4-BFCA on Fusarium strains since it acts as a possible candidate for the development of new therapies for the treatment of fusariosis.
Similar content being viewed by others
References
Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M (2015) Fusariosis. Semin Respir. Crit Care 36:706–714
Debourgogne A, Dorin J, Machouart M (2016) Emerging infections due to filamentous fungi in humans and animals: only the tip of the iceberg? Environ Microbiol 8:332–342
Diongue K, Ndiaye M, Seck MC, Diallo MA, Badiane AS, Ndiaye D (2017) Onychomycosis caused by Fusarium spp. in Dakar, Senegal: epidemiological, clinical, and mycological study. Dermatol Res Pract 2017:4.
Gupta C, Jongman M, Das S, Snehaa K, Bhattacharya SN, Seyedmousavi S, Van Diepeningen AD (2016) Mycopathologia 181:497–504
Al-Hatmi AMS, Curfs-Breuker I, De Hoog GS, Meis JF, Verweij PE (2017) Antifungal susceptibility testing of Fusarium: a practical approach. J Fungi 3:19
Batista BG, Dalla Lana DF, Silveira GP, SA MM, Ferreira M, Russo TVC, Canto RFS, Barbosa FAR, Braga AL, Kaminski TFA, De Oliveira LFS, Machado MM, Lopes W, Vainstein MH, Teixeira ML, Andrade SF, Fuentefria AM (2017) Allylic selenocyanates as new agents to combat Fusarium involved with human infections. ChemistrySelecty 2:11926–11932
Taj-Aldeen SJ (2017) Reduced multidrug susceptibility profile is a common feature of opportunistic fusarium species: Fusarium multi-drug resistant pattern. J Fungi 3:18
Rosa PD, Heidrich D, Corrêa C, Scroferneker ML, Vettorato G, Fuentefria AM, Goldani LZ (2017) Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis. Mycoses 60:616–622
Costa MI, Vilugron Rodrigues FAV, Vieira FF, Jarros IC, Kischkel B, Negri M, Becker TCA, Svidzinski TIE (2019) Effects of intratracheal Fusarium solani inoculation in immunocompetent mice. Microb Pathog 128:317–322
Van Diepeningen AD, Al-Hatmi AMS, Brankovics B, De Hoog GS (2014) Taxonomy and clinical spectra of Fusarium species: where do we stand in 2014? Curr Clin Microbiol Rep 1:10–18
Dabas Y, Bakhshi S, Xess I (2016) Fatal cases of bloodstream infection by Fusarium solani and review of published literature. Mycopathologia 181:291–296
Stempel JM, Hammond SP, Sutton DA, Weiser LM, Marty FM (2015) Invasive fusariosis in the voriconazole era: single-center 13-year experience. Open Forum Infect Dis 2:ofv099
Ersal T, Al-Hatmi ASM, Cilo DB, Curfs-Breuker I, Meis JF, Özkalemkaş F, Ener B, Van Diepeningen AD (2015) Fatal disseminated infection with Fusarium petroliphilum. Mycopathologia 179:119–124
McCarthy MW, Denning DW, Walsh T (2017) Future research priorities in fungal resistance. J Infec Dis 216:484–492
Wiederhold NP (2017) Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist 10:249–259
Katke SA, Amrutkar SV, Bhor RJ, Khairnar MV (2011) Synthesis of biologically active 2-chloro-N-alkyl/arylacetamide derivatives. Int J Pharm Sci Res 2:148–156
Karier P, Kraus G, Kolbe I (2017) Metazachlor traces in the main drinking water reservoir in Luxembourg: a scientific and political discussion. Environ Sci Eur 29:25
Marco-Contelles J, Gomez-Sanchez E (2005) New agents with antimycobacterial activity. Arch Pharm 338:562–563
Aschale M (2012) Synthesis and antimicrobial evaluation of some novel substituted 2-chloroacetanilides. Int J Chemtech Res 4:437–1441
Machado GRM, De Andrade SF, Pippi B, Bergamo VZ, Berlitz SJ, Lopes W, Lavorato SN, Külkamp-Guerreiro IC, Vainstein MH, Teixeira ML, Alves RJ, Fuentefria AM (2019) Chloroacetamide derivatives as a promising topical treatment for fungal skin infections. Mycologia 111:612–623
Lavorato SN, Duarte MC, De Andrade PHR, Coelho EAF, Alves RJ (2016) Synthesis, antileishmanial activity and QSAR studies of 2-chloro-N-arylacetamides. Braz J Pharm Sci 53:e16067
Harte AJ (2006) Gunnlaugsson T. Synthesis of α-chloroamides in water. Tetrahedron Lett 47:6321–6324
Singh DCP, Hashim SR, Singhal RG (2011) Synthesis and antimicrobial activity of some new thioether derivatives of quinoxaline. E-J Chem 8:635–642
Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard, 2ed edn. Wayne, PA: CLSI Document M38-A2. Clinical Laboratory Standards Institute.
Gill TA, Li J, Saenger M, Scofield SR (2016) Thymol-based submicron emulsions exhibit antifungal activity against Fusarium graminearum and inhibit Fusarium head blight in wheat. J Appl Microbiol 121:1103–1116
Joubert LM, Ferreira JAG, Stevens DA, Cegelski L (2015) Aspergillus fumigates biofilms: a comparison of processing techniques for scanning electron microscopy of fungal mycelium and extracellular matrix. Microsc Microanal 21:935–936
De Souza PC, Morey AT, Castanheira GM, Bocate KP, Panagio LA, Ito FA, Almeida RS (2015) Tenebrio molitor (Coleoptera: Tenebrionidae) as an alternative host to study fungal infections. J Microbiol Methods 118:182–186
Usui K, Nishida S, Sugita T, Ueki T, Matsumoto Y, Okumura H, Sekimizu K (2016) Acute oral toxicity test of chemical compounds in silkworms. Drug Discov Ther 10:57–61
Rodrigues A, Pina Vaz C, Fonseca AF, De-Oliveira JM (1993) Evaluating the concentration of a Candida albicans suspension. Infect Dis Obstet Gyneco 1:134–136
Jacobsen ID, Grobe K, Slesiona S, Hube B, Berndt A, Brock M (2010) Embryonated eggs as an alternative infection model to investigate Aspergillus fumigatus virulence. Infect Immun 78:2995–3006
Dalla Lana DF, Giuliani LM, Reolon JB, Lopes W, Vainstein MH, Danielli LJ et al (2018) Nanoemulsion improves the antifungal activity of allylic thiocyanates against yeasts and filamentous pathogenic fungi. ChemistrySelect 3:11663–11670
Liebert MA (1991) Final report on the safety assessment of chloroacetamide. J Am Coll Toxicol 10:21–22
Food and Drug Administration (FDA) (1987) Cosmetic product formulation data for Chloroacetamide. FDA Computer Printout.
ANVISA website. Available in http://portal.anvisa.gov.br/documents/10181/3285739/RDC_29_2012_.pdf/c74fbb1a c98b 4899–81ae-7ad9e18d807e. [accessed 25 March 2020].
Corrêa JCR, Salgado HRN (2011) Review of fluconazole properties and analytical for its determination. Crit Ver Anal Chem 4:270–279
Crowley PD, Gallagher HC (2014) Clotrimazole as a pharmaceutical: past, present and future. J Appl Microbiol 1:611–617
Kovacic P, Cooksy A (2012) Novel, unifying mechanism for amphotericin B and other polyene drugs: electron affinity, radicals, electron transfer, autoxidation, toxicity, and antifungal action. MedChemComm 3:274–328
Acknowledgements
The authors thank the Brazilian agencies Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS – EDITAL 04/2016 – PRONUPEQ 2016) for financial support and research fellowships. Alexandre Meneghello Fuentefria is grateful to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for the PQ fellowships (Edital Universal 2018).
Author information
Authors and Affiliations
Contributions
Gabriella da Rosa Monte Machado participated in the conceptualization, methodology, software, validation, formal analysis, investigation, data curation, writing—original draft preparation, and writing—review and editing of the text. Stefânia Neiva Lavorato participated in the methodology, validation, formal analysis, and data investigation. William Lopes and Mário Teixeira participated in the methodology, data curation, and formal analysis. The professors Marilene Henning Vainstein, Ricardo José Alves, Saulo Fernandes de Andrade, and Alexandre Meneghello Fuentefria participated in the visualization, supervision, project administration, and acquisition of the financial support.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Responsible Editor: Carlos Pelleschi Taborda
Rights and permissions
About this article
Cite this article
da Rosa Monte Machado, G., Neiva Lavorato, S., Lopes, W. et al. A chloroacetamide derivative as a potent candidate for fusariosis treatment. Braz J Microbiol 53, 1289–1295 (2022). https://doi.org/10.1007/s42770-022-00771-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42770-022-00771-9